Skip to content
    KKR
    Earnings call· Mar 2025(Q1 FY25)

    KKR & Co. Q1 FY25 earnings call KKR

    May 1, 2025 Source

    Executive summary

    KKR Q1 FY25 — Strong Earnings and Strategic Deployment Amidst Volatility

    KKR delivered robust Q1 FY25 results, showcasing strong fee-related and total operating earnings driven by significant capital raising and strategic deployment. The firm is actively investing into volatile markets, leveraging its global and diversified model, with a record high in unrealized performance income. Management remains confident in its 2026 guidance and long-term growth strategy, particularly in private wealth and insurance, despite near-term market uncertainties.

    Highlights

    5
    • Fee-related earnings per share (FRE per share) increased 22% year-over-year to $0.92.

    • Total operating earnings per share grew 16% year-over-year to $1.24.

    • Adjusted net income per share rose 19% year-over-year to $1.15.

    • Total new capital raised in Q1 was $31 billion, with North America XIV closing at $14 billion in April.

    • Gross unrealized performance income reached a high of $8.7 billion, up over 25% year-on-year.

    Concerns

    3
    • Management noted potential for some sale processes to be delayed if market volatility continues.

    • Capital Markets transaction fees for Q2 are expected to be "a little bit shy" of Q1's $229 million due to lower deal flow.

    • Insurance segment operating earnings are expected to remain around $250 million plus or minus for the next few quarters, reflecting intentional near-term under-earning for long-term benefits.

    Guidance & targets

    4
    CategoryTargetConfidence
    2026 Fundraising and Financial Metrics
    Feel good about those numbers
    high materiality
    High
    Insurance segment operating earnings
    $250 million plus or minus
    medium materiality
    High
    Management fee growth
    Accelerate from here
    high materiality
    High
    North America XIV activation
    Activated in Q2 of 2025
    high materiality
    High

    Segment performance

    3
    SegmentRevenueYoYQoQMargin
    Asset Management
    Strong fee-related revenue growth driven by fundraising and deployment, with a healthy FRE margin. Monetization activity saw significant year-over-year growth.
    Fee-related earnings: $823 millionFee-related earnings per share: $0.92Management fees: $917 millionManagement fee growth YoY: 13%Total transaction and monitoring fees: $262 millionCapital Markets transaction fees: $229 millionFee-related performance revenues: $21 millionFee-related compensation: 17.5% of fee-related revenuesOther operating expenses: $168 millionRealized performance income: $348 millionRealized investment income: $218 millionTotal monetization activity: $566 millionTotal monetization activity growth YoY: almost 40%
    $1.2 billion22%69%
    Insurance Segment
    Operating earnings were in line with expectations. The segment is undergoing a strategic evolution to increase alternatives exposure and third-party capital, aiming for 20%+ all-in pretax ROE.
    Operating earnings: $259 millionAll-in pretax ROE: approaching 20%
    $259 million
    Strategic Holdings
    Operating earnings were in line with expectations. The segment closed on additional stakes in 3 core private equity businesses and announced a new acquisition (Karo Healthcare), expanding the portfolio to 19 companies.
    Operating earnings: $31 millionShare of annual revenue from 18-company portfolio: approximately $3.8 billionShare of annual EBITDA from 18-company portfolio: approximately $920 million
    $31 million

    Operational metrics

    87
    Fee-related earnings per share
    $0.92up 22% year-over-year
    Q1 FY25
    Total operating earnings per share
    $1.24up 16% year-over-year
    Q1 FY25
    Adjusted net income per share
    $1.15up 19% compared to a year ago
    Q1 FY25
    Management fees
    $917 millionup 13% year-over-year
    Q1 FY25
    Total transaction and monitoring fees
    $262 million
    Q1 FY25
    Capital Markets transaction fees
    $229 million
    Q1 FY25
    Fee-related performance revenues
    $21 million
    Q1 FY25
    Fee-related revenues
    $1.2 billionup 22% year-over-year
    Q1 FY25
    Fee-related compensation
    17.5%midpoint of guided range
    Q1 FY25
    Other operating expenses
    $168 million
    Q1 FY25
    FRE margin
    69%
    Q1 FY25
    Insurance segment operating earnings
    $259 million
    Q1 FY25
    Strategic Holdings operating earnings
    $31 million
    Q1 FY25
    Total operating earnings composition
    nearly 80%
    LTM

    Represents the more recurring components of earnings streams.

    Realized performance income
    $348 million
    Q1 FY25
    Realized investment income
    $218 million
    Q1 FY25
    Total monetization activity
    $566 millionup almost 40% year-over-year
    Q1 FY25
    Private equity portfolio performance
    4%
    Q1 FY25
    Private equity portfolio performance
    11%
    LTM
    Opportunistic real estate portfolio performance
    2%
    Q1 FY25
    Opportunistic real estate portfolio performance
    5%
    LTM
    Infrastructure portfolio performance
    4%
    Q1 FY25
    Infrastructure portfolio performance
    13%
    LTM
    Leveraged credit composite performance
    flat
    Q1 FY25
    Leveraged credit composite performance
    7%
    LTM
    Alternative credit composite performance
    3%
    Q1 FY25
    Alternative credit composite performance
    11%
    LTM
    Dividend per share (annualized)
    $0.74increased from $0.50
    Annualized

    Beginning with Q1 FY25.

    Dividend per share (quarterly)
    $0.185
    Quarterly

    Beginning with Q1 FY25.

    Gross unrealized performance income
    $8.7 billionup over 25% year-on-year
    Q1 FY25

    High point for the firm.

    Pending monetization revenue
    north of $800 million
    Future

    Based on signed but not yet closed transactions.

    Expected Q2 monetization revenue
    at least $250 million
    Q2 FY25

    Part of the pending monetization pipeline.

    Total new capital raised
    $31 billion
    Q1 FY25
    North America XIV initial close
    $14 billion
    April FY25
    Committed capital across active traditional private equity flagship funds
    over $40 billion
    Q1 FY25

    Excludes core private equity, mid-market, and growth strategies.

    K-Series AUM
    $22 billioncompared to $9 billion a year ago
    April FY25

    Across 4 investing verticals.

    Insurance all-in pretax ROE
    approaching 20%
    Q1 FY25

    Clear path to 20-plus percent returns.

    Committed but uncalled capital
    $116 billion
    Q1 FY25
    Capital not yet earning fees
    $64 billionup almost 50% compared to 1 year ago
    Q1 FY25

    Fees turn on when capital is invested or enters investment period.

    Management fees (Private Equity)
    over $1 billion
    LTM
    Management fees (Real Assets)
    over $1 billion
    LTM
    Management fees (Credit and Liquid Strategies)
    over $1 billion
    LTM
    Management fees (aggregate)
    high teens
    Past 3 years
    Share of annual revenue from Strategic Holdings portfolio
    $3.8 billion
    Annual

    KKR's share across 18 companies.

    Share of annual EBITDA from Strategic Holdings portfolio
    $920 million
    Annual

    KKR's share across 18 companies.

    Asset-based finance AUM
    $74 billionup 35-40%
    Q1 FY25

    Within private credit.

    Asset-based finance deployment
    $4 billion
    Q1 FY25
    Asset-based finance deployment
    $21 billionup from $8 billion in 2023
    TTM
    Capital Markets transaction fees (Q2 outlook)
    a little bit shy of Q1
    Q2 FY25

    Due to lower deal flow, but pipeline is solid.

    Capital Markets transaction fees (historical)
    roughly $600 million
    FY22 and FY23

    Protected downside in choppy markets.

    Capital Markets transaction fees (historical)
    roughly $1 billion
    FY24

    When markets opened up.

    Debt-focused transaction fees
    2/3consistent over time
    Q1 FY25
    Insurance alternatives exposure added
    $1 billion
    Q1 FY25
    Insurance retail annuity duration (5+ years)
    90%up from 65% a year ago
    Q1 FY25

    Of annuities sold in retail channel.

    Japan Post strategic partnership investment
    $1 billion to $2 billion
    Q1 FY25

    Intention to expand existing partnership.

    Capital Markets fees from insurance
    $50 million
    FY24

    Potential to generate several hundred million annually over time.

    Capital Markets fees from insurance
    $20 million
    Q1 FY25
    Capital is perpetual or committed
    over 90%
    Q1 FY25
    Management fees calculation basis
    Q1 FY25

    Largely calculated on committed or invested capital, not influenced by marks/NAVs.

    Investment professionals outside U.S.
    almost half
    Q1 FY25
    China-based LPs as % of AUM
    low single-digit percentage
    Q1 FY25
    Private wealth new capital raised
    $4 billion
    Q1 FY25

    Across K-Series.

    Private wealth new capital raised
    $1 billion
    April FY25

    Across K-Series.

    Total capital raised (last 2 years)
    over $200 billion
    Last 2 years
    Flagship capital as % of total raised
    about 12%
    Last 2 years
    Share of KKR owned by senior management
    roughly 30%
    Q1 FY25
    Shares retired through buybacks
    roughly 10%
    Historical
    Free float retired through buybacks
    15%
    Historical
    Average buyback price
    $28
    Historical
    Credit AUM
    $280 billionup 10% year-over-year
    Q1 FY25
    Private credit AUM
    $117 billionup 26%
    Q1 FY25
    Asia AUM
    $70 billionup from $21 billion at end of 2019
    Q1 FY25
    Asia AUM (2019)
    $21 billion
    End of 2019
    Private wealth flows (Q1, US vs non-US)
    roughly half inside U.S., roughly half outside U.S.
    Q1 FY25

    For private equity and infrastructure.

    Private wealth flows (April, US vs non-US)
    pretty equal split both inside and outside U.S.
    April FY25
    Infra Fund V AUM
    a little over $11 billion
    Q1 FY25
    Infra Fund V first close period
    July of '24
    July FY24
    Americas Private Equity capital returned vs called
    2x
    Last 8 years
    Industry average alternatives exposure for insurance
    5% to 8%
    Current
    Global Atlantic alternatives exposure
    1%
    End of last quarter
    Capital Markets business revenue (2022, 2023)
    roughly $600 million
    FY22 and FY23
    Capital Markets business revenue (2024)
    roughly $1 billion
    FY24
    Leveraged finance market spreads
    a little bit higher
    Early May FY25
    S&P 500 performance
    down 1%
    Since April 1
    KKR stock performance
    down 5%
    Since beginning of year
    US GDP as % of global GDP
    25%
    Current
    US market cap as % of global market cap
    65%
    Current

    Industry KPIs

    5
    MetricValueDetails
    Fee rateabout 100 basis pointsbps
    Fundraising inflows$31 billionUSD
    Performance revenue$21 millionUSD
    Fee related earnings$823 millionUSD
    Deployment realizationsover $30 billionUSD

    Product announcements

    3
    ProductTypeDetails
    Public-private credit solutionslaunch
    Private equity and real asset productsroadmap
    Model portfolios and target date fundsroadmap

    Deals & partnerships

    3
    Karo HealthcareNew core private equity investment.

    Announced since quarter end.

    Capital GroupExclusive partnership to launch public-private credit solutions.

    Two public-private credit solutions launched earlier this week.

    Japan Post InsuranceExpansion of existing strategic partnership and new investment.$1 billion to $2 billion

    Announced intention to expand partnership and make a new investment in Q1.

    Risks & headwinds

    4
    Tariffs and supply chain disruptionsCurrent

    90% of our AUM has limited to no first order impact from the announced tariffs (private equity portfolio); vast majority of our companies have either contractual protections that insulate KKR returns or minimal estimated exposure (infrastructure platform); pockets of exposure (credit portfolio).

    Mitigation: Proactive supply chain diversification and resilience efforts over 5+ years; active implementation of mitigating measures; contractual protections in infrastructure; global and diversified portfolio.

    Market volatility and lower deal flowQ2 FY25

    Capital Markets transaction fees for Q2 might be "a little bit shy" of Q1's $229 million.

    Mitigation: Strong pipeline; diversified business model that performs well in different market environments; ability to monetize gains even in volatile markets.

    Potential delay in sale processesOngoing

    some sale processes may be delayed if this continues

    Mitigation: Mature and global portfolio with record embedded gains; good line of sight to several assets in sale processes; ability to monetize later if delays occur.

    Near-term pressure on insurance operating earningsNext few quarters

    Insurance segment operating earnings expected to stay around "$250 million plus or minus" for next few quarters.

    Mitigation: Intentional evolution of business model for long-term economic profile; focus on elongating liabilities, increasing alternatives exposure, and raising third-party capital to achieve 20%+ all-in pretax ROE.

    What to watch in Q2 FY25

    5

    North America XIV activation and fee contribution

    Q2 FY25
    CurrentInitial close at $14 billion in April, not yet contributing to Q1 management fees.
    TargetPartial benefit to Q2 management fees.

    Why it matters

    This is a major flagship fund, and its activation will significantly impact management fee growth, a key driver of FRE.

    I can tell you that [ NAX IV ] will be activated in Q2 of 2025, so in this current quarter we're in right now. And so it will be a partial benefit to the Q2 quarter.

    Q&A highlights

    7

    Impact of emerging trade war on KKR's Asia strategy, fundraising, and investing efforts.

    KKR's strategy in Asia remains unchanged, having learned from past tariff implications and supply chain disruptions. The firm's cross-asset class, pan-Asia presence, and focus on intra-Asia trade position it well. Asia AUM has grown significantly with diversification.

    No change to our strategy. I mean one of the things we talked about in the prepared remarks is that we learned a lot kind of going through Trump 1.0 and thinking about tariff implications, learned a lot during COVID about supply chains as an example.

    asked by Craig Siegenthaler · answered by Scott Nuttall

    2 min read6 chapters

    Detailed Narrative

    01

    Resilient Business Model Amidst Volatility

    KKR emphasized the durability and diversification of its business model, particularly in the face of recent market volatility🌐 and tariff concerns. The firm's global presence and multi-asset class approach allow it to lean into attractive investment opportunities when others are hesitant, with 90% of its AUM having limited first-order impact from announced tariffs. This resilience is a result of proactive strategies implemented over the past five years, including supply chain diversification.

    02

    Strategic Deployment and Monetization

    KKR has been actively deploying capital, committing over $30 billion in new investments since the start of the year, with more than half outside the U.S. Notably, $10 billion of equity was committed in the last month alone, diversified across private markets and private credit. The firm also highlighted a record $8.7 billion in gross unrealized performance income, up over 25% year-on-year, and a strong pipeline of pending monetizations, with over $800 million in sight, including $250 million expected in Q2.

    03

    Robust Capital Raising Efforts

    Despite market uncertainties, KKR maintains conviction in its fundraising outlook. The firm raised $31 billion in Q1, including a $14 billion initial close for North America XIV. Private wealth initiatives, particularly the K-Series suite, continue to gain traction with $22 billion in AUM, up from $9 billion a year ago. New public-private credit solutions were also launched with Capital Group, targeting broader investor access.

    04

    Evolving Insurance Strategy

    KKR is progressing with the evolution of its Global Atlantic business, focusing on elongating liabilities, increasing alternatives exposure (adding $1 billion in Q1), and raising third-party capital. This strategy aims for a sustainable 20%+ all-in pretax ROE for the insurance business, even if it means intentional near-term under-earning in insurance segment operating earnings. Progress includes 90% of Q1 retail annuities having 5+ year durations, up from 65% a year ago.

    05

    Capital Markets Performance and Outlook

    The Capital Markets business delivered a solid $229 million in transaction fees in Q1, with approximately two-thirds debt-focused, consistent with historical trends. While Q2 fees might be slightly lower due to market conditions, the team feels well-positioned, having built a business that provides downside protection in choppy markets (generating ~$600 million in FY22/FY23) and significant upside when markets open up (reaching ~$1 billion in FY24).

    06

    Long-term Growth and Capital Allocation

    KKR reiterated its confidence in achieving its 2026 guidance, driven by scaling existing initiatives and a focus on long-term EPS growth and earnings quality. The firm's capital allocation strategy prioritizes share buybacks, core private equity investments, strategic M&A, and insurance, with management's significant ownership (roughly 30%) aligning interests with shareholders. Historically, KKR has retired 10% of shares outstanding at an average price of $28 per share.

    AI-generated summary of the company’s earnings call. Not investment advice.